Literature DB >> 9379257

Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins.

J A Martin1, S M Ellerbroek, J A Buckwalter.   

Abstract

The synthetic activity of chondrocytes in articular cartilage declines with age, possibly as a result of decreased sensitivity to anabolic growth factors such as insulin-like growth factor-I. The sensitivity of these cells to insulin-like growth factor-I is regulated, in part, by the synthesis of insulin-like growth factor-I binding proteins. We hypothesized that, as cartilage ages, an increase in the expression of these binding proteins suppresses the synthetic response of chondrocytes to insulin-like growth factor-I. To test this hypothesis, we measured proteoglycan synthesis (incorporation of [35S]sulfate per cell) in alginate cultures of chondrocytes from the articular cartilage of 1, 3, 12, and 24-month-old rats. A dose-response to insulin-like growth factor-I was determined for cells from each age group; incorporation of [35S]sulfate per cell declined with age, regardless of the dose. The sharpest decline was found between cells from the 1 and 3-month-old groups. Using the Western ligand blot technique, we then compared the expression of insulin-like growth factor-I binding protein in chondrocytes from the 1 and 3-month-old rats and found that it was increased in the cells from the older animals. Recombinant insulin-like growth factor-3, when added to the cell cultures of the 1-month-old rats, inhibited incorporation of [35S]sulfate and blocked responses to insulin-like growth factor-I. These findings suggest that the age-related decline in the synthetic response of chondrocytes to insulin-like growth factor-I results, at least in part, from increased expression of insulin-like growth factor binding protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379257     DOI: 10.1002/jor.1100150403

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  48 in total

1.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

2.  Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth factor I (IGF-I) overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis.

Authors:  Anja Weimer; Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Janina Frisch; Anna Wezel; Jochen Jung; Dieter Kohn; Ernest F Terwilliger; Stephen B Trippel; Magali Cucchiarini
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 3.  OA in 2011: Age-related OA--a concept emerging from infancy?

Authors:  Thomas Aigner; Wiltrud Richter
Journal:  Nat Rev Rheumatol       Date:  2012-01-10       Impact factor: 20.543

4.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

Review 5.  Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis.

Authors:  J A Martin; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2001

Review 6.  Events in articular chondrocytes with aging.

Authors:  Daniel J Leong; Hui B Sun
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

7.  Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis.

Authors:  Brett C Geiger; Sheryl Wang; Robert F Padera; Alan J Grodzinsky; Paula T Hammond
Journal:  Sci Transl Med       Date:  2018-11-28       Impact factor: 17.956

8.  Effects of dexamethasone on the functional properties of cartilage explants during long-term culture.

Authors:  Liming Bian; Aaron M Stoker; Kevin M Marberry; Gerard A Ateshian; James L Cook; Clark T Hung
Journal:  Am J Sports Med       Date:  2009-12-03       Impact factor: 6.202

9.  Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis.

Authors:  John D Cravero; Cathy S Carlson; Hee-Jeong Im; Raghunatha R Yammani; David Long; Richard F Loeser
Journal:  Arthritis Rheum       Date:  2009-02

10.  Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage.

Authors:  R F Loeser; H-J Im; B Richardson; Q Lu; S Chubinskaya
Journal:  Osteoarthritis Cartilage       Date:  2008-09-30       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.